Dilip Surana

Net Worth

$1.284B

0% (24h)

Dilip Surana, the Chairman and Managing Director of Micro Labs, is a leading figure in the pharmaceutical industry. With a current net worth of $1.3 billion, his wealth stems from his leadership of Micro Labs, a company specializing in the development and manufacture of pharmaceutical products. His career began in 1983 when he joined the family business after completing his bachelor's degree in commerce. Surana has played a pivotal role in transforming Micro Labs into a global enterprise, focusing on innovation and quality. Under his leadership, the company expanded its global presence with facilities in various countries. Surana is known for his ethical business practices and commitment to corporate social responsibility, as evidenced by his philanthropic initiatives through the GDA Foundation, founded by his father, which supports hospitals, schools, and research centers.

The Full Dossier

Early Life

Dilip Surana was born on January 18, 1966, in Bangalore, India. He completed his schooling at Bishop Cotton Boys High School in Bangalore and later graduated with a Bachelor of Commerce (Accounts) degree from St. Joseph's College of Commerce-Bangalore University in 1987. His early exposure to the pharmaceutical industry came from his father, G.C. Surana, the founder of Micro Labs, which inspired him to carry on the family legacy. He officially joined Micro Labs in 1983 after completing his degree.

Rise to Success

Dilip Surana's journey with Micro Labs began at a time when the company was still growing. He took over the operations and rapidly absorbed the nuances of corporate management, growing the company into a global pharmaceutical enterprise. His focus on quality, ethics, and customer satisfaction, along with his people-centric approach, helped Micro Labs achieve significant growth. Under his leadership, Micro Labs expanded its footprint to over 50 countries, establishing 17 manufacturing plants in India and several research and development centers. The company's flagship product, Dolo-650, became a household name during the COVID-19 pandemic, contributing significantly to the company's revenue.

Key Business Strategies

Surana's leadership is marked by several key business strategies. He emphasized innovation and research and development, investing heavily in these areas to develop proprietary products. The company's focus has been on providing quality healthcare solutions at affordable costs. Micro Labs has also established specialized business units focusing on various therapeutic segments, a strategy that helped in targeted research and marketing. Furthermore, Surana has emphasized the importance of ethical and sustainable business practices, which has enhanced the company's reputation.

Philanthropy

Dilip Surana is actively involved in philanthropy through the GDA Foundation, founded by his father. The foundation supports hospitals, schools, and research centers and provides free medical assistance and scholarships.

Career Timeline

1994

Introduced specialty divisions

Pioneered the concept of specialty divisions in the Indian Pharmaceutical Industry, focusing on Cardiology, Neuropsychiatry, and Ophthalmology.

1988

Managing Director, Micro Labs Ltd.

Became Managing Director, playing a key role in the growth and expansion of Micro Labs.

1983

Joined Micro Labs

Joined the family business after completing his bachelor's degree in commerce.

Philanthropic Impact

Education and HealthcareUndisclosed

GDA Foundation

Supports hospitals, schools, and research centers and provides free medical assistance and scholarships.